Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biological & Pharmaceutical Bulletin|February 3, 2007
Rakicidin A: a hypoxia-selective cytotoxinYohko Yamazaki, Setsuko Kunimoto, Daishiro Ikeda
Oncology Research|September 25, 2023
Deoxynortryptoquivaline: A unique antiprostate cancer agentYohko Yamazaki, Manabu Kawada, Isao Momose
Biological & Pharmaceutical Bulletin|April 4, 2003
HIF-1-dependent VEGF reporter gene assay by a stable transformant of CHO cellsYohko Yamazaki, Kiyoshi Egawa, Kiyoshi Nose, et al.
Cancer Science|June 9, 2004
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvationJie Lu, Setsuko Kunimoto, Yohko Yamazaki, et al.
The Journal of Antibiotics|March 16, 2004
Kigamicins, novel antitumor antibiotics. II. Structure determinationSetsuko Kunimoto, Tetsuya Someno, Yohko Yamazaki, et al.
Chemical & Pharmaceutical Bulletin|July 5, 2016
Synthesis of Androprostamine A and ResormycinHikaru Abe, Yohko Yamazaki, Chiharu Sakashita, et al.
Biological & Pharmaceutical Bulletin|October 4, 2006
Anthracyclines, small-molecule inhibitors of hypoxia-inducible factor-1 alpha activationYohko Yamazaki, Yuki Hasebe, Kiyoshi Egawa, et al.
The Journal of Antibiotics|July 29, 2021
Androprostamine A: a unique antiprostate cancer agentYohko Yamazaki, Hikaru Abe, Chiharu Sakashita, et al.
The Journal of Biological Chemistry|September 26, 2020
Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibitionTakefumi Onodera, Isao Momose, Hayamitsu Adachi, et al.
The Journal of Antibiotics|October 2, 2014
Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8Yohko Yamazaki, Tetsuya Someno, Masayuki Igarashi, et al.
Pageof 2